Finny logo
Finny logo

IBB vs IDNA

IBB is an ETF, whereas IDNA is a mutual fund. IBB has a lower expense ratio than IDNA (0.46% vs 0.47%). Below is the comparison between IBB and IDNA.

IBB IDNA
Security Type ETF Mutual fund
Segment Equity: U.S. Biotech N/A
Issuer BlackRock iShares
Net Assets $10.91B $274.1M
Expense Ratio 0.46% 0.47%
Management Style passive (index-based) passive
Dividend Yield 0.21% 0.26%
Minimum Investment N/A N/A
YTD Return 3.59% 2.33%
1-Year Return 38.14% 5.24%
3-Year Return 13.46% N/A
5-Year Return 13.38% N/A
10-Year Return 17.61% N/A

IBB description

The Fund seeks to track the investment results of the NASDAQ Biotechnology Index composed of biotechnology and pharmaceutical equities listed on the NASDAQ Stock Market. The Fund invests at least 90% of its assets in securities of the Underlying Index and in depositary receipts representing securities of the Index.

IBB performance & returns

YTD Return 3.59%
1-Month Return -2.31%
3-Month Return 8.29%
1-Year Return 38.14%
3-Year Return 13.46%
5-Year Return 13.38%
10-Year Return 17.61%
IBB expense ratio is 0.46%.

IBB holdings

Top 10 Holdings (46.86% of Total Assets)

Name Symbol % Assets
Gilead Sciences Inc GILD 7.48%
Amgen Inc AMGN 7.35%
Regeneron Pharmaceuticals Inc REGN 6.30%
Vertex Pharmaceuticals Inc VRTX 6.02%
Illumina Inc ILMN 4.74%
Biogen Inc BIIB 3.76%
Seagen Inc Ordinary Shares SGEN 3.26%
Moderna Inc MRNA 2.99%
Alexion Pharmaceuticals Inc ALXN 2.83%
Incyte Corp INCY 2.13%

Other relevant IBB comparisons

You may also want to check out the following IBB comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

IDNA description

The Fund seeks to track the investment results of NYSE FactSet Global Genomics and Immuno Biopharma Index. The Fund invests at least 90% of its assets in the components of the Index, which measures the performance of equity securities issued by companies in the biopharmaceutical and healthcare equipment and services.

IDNA performance & returns

YTD Return 2.33%
1-Month Return -6.63%
3-Month Return 5.24%
1-Year Return 5.24%
3-Year Return N/A
5-Year Return N/A
10-Year Return N/A
IDNA expense ratio is 0.47%.

IDNA holdings

Top 10 Holdings (45.18% of Total Assets)

Name Symbol % Assets
Mirati Therapeutics Inc MRTX 8.31%
Merck KGaA MRK.DE 4.62%
Invitae Corp NVTA 4.50%
Moderna Inc MRNA 4.31%
Genmab A/S GMAB 4.27%
Iovance Biotherapeutics Inc IOVA 4.22%
Seagen Inc Ordinary Shares SGEN 4.18%
CRISPR Therapeutics AG CRSP 3.89%
Kyowa Kirin Co Ltd 4151 3.47%
Sarepta Therapeutics Inc SRPT 3.41%

Other relevant IDNA comparisons

You may also want to check out the following IDNA comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
Follow Us